Page 35 - Johnson Private News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 08-Apr-2021 Byler Disease Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- AstraZeneca PLC, Pfizer Inc, Bristol-Myers Squibb Company, Gilead Science Inc., Johnson & Johnson Private Limited The global byler disease is majorly dominated by the surgical treatment among treatment segment. Among the surgical treatment, laser surgery becoming more popular as they can be used to treat or repair different part of the body to find out the location of the disease which is then followed by cryosurgery, a procedure which ...

Search jobs 16-Mar-2021 Global Corneal opacity Market 2021:Size,Share,Trends,Competitive Analysis,Outlook,Forecast To 2028||Players-Lifecell Corporation, Medtronic, Kohler GmbH, Exactech Inc., Cryolife Inc., Rganogenesis Inc., CorNeat Vision Ltd., Aurolab, Argus Biomedical Pty Ltd, Presbia PLC A new research study from “Data Bridge Market Research”  with title Corneal Opacity Insights 2021, Global  Analysis and Forecast to 2028 provides an in-depth assessment of the Corneal Opacity  including key market trends, upcoming technologies, industr...

VALLEY COTTAGE, N.Y. – Impact of COVID-19 on the Healthcare IndustryThe COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the...

India Diabetes Care Market Competition, Forecast & Opportunities, 2027 News provided by Share this article Share this article ResearchAndMarkets.com's offering. The Indian Diabetes Care Market was valued at USD1530.3 million in value terms in FY2020 and is forecast to grow at CAGR of 7.94% in value terms to reach USD2408.39 million by FY2026. The Indian Diabetes Care Market is witnessing consistent growth, owing to the increasing geriatric population, increasing diabetic population and the adoption of an unhealthy lifestyle leading to obesity that further increases the diabetic population. M...

NCPCR summons DCGI over lack of standard testing for carcinogens in J&J's baby products According to NCPCR, there is no uniformity in the testing methods used by labs to detect the presence of formaldehyde and asbestos in J&J's products PTI | March 5, 2021 | Updated 08:21 IST J&J's baby products came under the scanner in March 2019 when drug inspectors in Rajasthan claimed that they had found formaldehyde in two batches of its 'No More Tears' baby shampoo The National Commission for Protection of Child Rights on Thursday issued summons to the Drug Controller General of India (DCGI) and the C...